Takeda Issues Voluntary Product Withdrawal
Takeda today announced that it is conducting a voluntary market withdrawal for two product lots of 650 IU VONVENDI® [von Willebrand factor] in the U.S. Takeda announced that the withdrawal is being conducted out of an abundance of caution due to misprinted product labels with the incorrect expiration date. The expiration date printed on the label on the outside of the package of the affected lots is six months after the actual expiration date (January 27, 2025).
Please note that HFA does not recommend, endorse, or make any representation about the efficacy, appropriateness, or suitability of any specific products, treatments, or opinions. If you have any questions or concerns about your medical treatment, please consult your physician.
You can read the full Takeda announcement here.
Source: Hemophilia Federation of America, January 2024